ACV in Taiwan. What’s Next? A Review of ACV’s strategies and future in Taiwan.

Simple item page
dc.contributor沈永正zh_TW
dc.contributorShen, Yung-Chengen_US
dc.contributor.authorPOWEN LEEzh_TW
dc.contributor.authorLee, Po-Wenen_US
dc.date.accessioned2019-09-03T09:53:22Z
dc.date.available不公開
dc.date.available2019-09-03T09:53:22Z
dc.date.issued2017
dc.description.abstract無中文摘要zh_TW
dc.description.abstractA proud family-owned dermatological pharmaceutical company started in Auckland, New Zealand in 1950, ACV Healthcare began its global invasion in the 1990s. After successful landing in the Middle East after the gulf war, ACV turned its attention to the (South) East Asia countries, Hong Kong, Singapore, Malaysia and Taiwan. More than a decade after investing in the region, Taiwan remains as one of ACV’s biggest headache in Asia. Not only did it experience a series of setbacks including mediocre performances, parting ways with its long-term distributor, and its country manager recently, ACV also faces transformation from a more medical channel focus strategy to consumer channels focus. This paper highlights some of the difficulties ACV faces in the marketplace in the past five years and ACV’s strategies in terms of pricing, channel and HR.en_US
dc.description.sponsorship國際企業管理雙碩士學位學程(NTNU-USC DIMBA)zh_TW
dc.identifierG0105596104
dc.identifier.urihttp://etds.lib.ntnu.edu.tw/cgi-bin/gs32/gsweb.cgi?o=dstdcdr&s=id=%22G0105596104%22.&%22.id.&
dc.identifier.urihttp://rportal.lib.ntnu.edu.tw:80/handle/20.500.12235/94454
dc.language英文
dc.subjectCosmeticszh_TW
dc.subjectPharmaceuticalzh_TW
dc.subjectACVzh_TW
dc.subjectPharmaceuticalen_US
dc.subjectACVen_US
dc.subjectCosmeticsen_US
dc.titleACV in Taiwan. What’s Next? A Review of ACV’s strategies and future in Taiwan.zh_TW
dc.titleACV in Taiwan. What’s Next? A Review of ACV’s strategies and future in Taiwan.en_US

Files

Collections

學位論文